Team

Dr. Grace Xiaolu Yang

COO, VP of Research & Co-founder

Biography

“We hope Tality will become a safe and effective option of cancer care that helps patients manage their disease.”

Dr. Yang is a founder of Filtricine. She leads business and scientific operations at Filtricine. She is an inventor on the two patent applications filed by Filtricine.

Dr. Yang holds a PhD from Stanford University.

Our Team

Dr. John Chant
CEO
Mike Partsuf
Senior Food Scientist
Emily Sinovic
Public Relations Consultant
Todd Lorenz
Clinical Development Consultant

Our Advisors

Dr. Mike P Snyder
Stanford University School of Medicine
Peter B Hutt
Senior Counsel at Covington & Burling LLP
Brad Barnes
Culinary Institute of America
Dr. Dariush Mozaffarian
Tufts University
Dr. Yung-Chi Cheng
Yale University School of Medicine
Dr. Danhua Xiao
Atlantic Health Metabolic Center
Dr. Joseph V Rodricks
Ramboll (formerly ENVIRON)
Alister Thomson
Bristol Myers Squibb (Former)
Jeff Depew
Sand Hill Angels
Dr. Wei Jiang
Medical Affairs at MorphoSys

Our Board of Directors

Dr. John Chant
CEO
Dr. Xiyan Li
Co-founder
Dr. Rami El Assal
Founding Partner at Boutique Venture Partners
Drew Lanza
Founding Partner at Berkeley Catalyst Fund
We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2024 Filtricine, Inc. All Rights Reserved | by Wuilt